William Pittman signed a petition to legalize medical marijuana in Mississippi, believing it could aid in treating his borderline personality disorder, binge eating disorder, and ADHD. As he signed, he expressed skepticism to his husband, anticipating complications in accessing the treatment. True to his concerns, he found it challenging to trust the state to deliver on its promises, particularly after the Mississippi Supreme Court nullified the initiative that would allow doctors to prescribe cannabis for various conditions deemed necessary.
This skepticism reflects a broader sentiment among state officials who initially supported medical cannabis but were disappointed with the legislative compromises necessary to secure votes, especially following the court’s decision in May 2021. Shea Dobson, former mayor of Ocean Springs and an early cannabis advocate, noted that his support waned as the situation evolved. Dobson now serves as the executive director of the Citizens’ Alliance of Mississippi, which advocates for medical cannabis.
Medical Cannabis Legislation Overview
The recently adopted law permits medical cannabis use for debilitating conditions such as cancer, Parkinson’s disease, HIV/AIDS, and PTSD, among others. However, Pittman’s specific diagnoses do not qualify under the 28 conditions listed by the Mississippi Department of Health. He has refrained from applying for a medical cannabis card set to be established by the end of May 2023.
The Health Department is tasked with creating regulations regarding cannabis product licensing, while the Department of Revenue will oversee dispensaries. Municipalities have until May 3 to decide whether to permit cannabis-related businesses; areas like Brandon and Ridgeland have opted out, limiting access for eligible patients seeking medical cannabis.
Concerns About Accessibility and Taxes
State Rep. Janson Owen opposed the final vote due to excise taxes imposed on growers, suggesting these costs would burden patients needing assistance. The Governor, Tate Reeves, acknowledged that while the legislation was not ideal, it was a necessary compromise.
Despite some research suggesting potential benefits of cannabis for mental health conditions, the Mississippi Psychiatric Association has not endorsed its use due to a lack of FDA regulation and data supporting efficacy for psychiatric disorders. Ongoing studies reveal mixed results, although some indicate that cannabis might alleviate anxiety symptoms.
Mississippi’s Medical Cannabis Market
Pittman currently manages multiple medications but experiences side effects that complicate his daily life as a data journalist. Insured but not qualifying for public assistance, he faces high costs for alternative ADHD medications. Should he eventually qualify for medical cannabis, state regulations limit purchases to six units of 3.5 grams per week.
Currently, eligible patients will have access to a range of cannabis products through licensed dispensaries, provided they comply with the state’s strict regulations. As Mississippi evolves its cannabis landscape, advocates emphasize the importance of enabling patients to access necessary treatments without legal repercussions.
In a complex cannabis market, Dobson maintains optimism for patients and emphasizes the goal of making medicinal options widely available.
